Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0056 | 0.0975 | 0.0975 |
Onchocerca volvulus | 0.0248 | 1 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.0901 | 0.0765 |
Mycobacterium ulcerans | phosphotyrosine protein phosphatase PtpA | 0.0209 | 0.8175 | 0.5 |
Giardia lamblia | Low molecular weight protein-tyrosine-phosphatase | 0.0209 | 0.8175 | 0.5 |
Loa Loa (eye worm) | pax transcription factor protein 2 | 0.0248 | 1 | 1 |
Trichomonas vaginalis | low molecular weight protein tyrosine phosphatase, putative | 0.0209 | 0.8175 | 1 |
Echinococcus granulosus | phosphatidylinositol 5 phosphate 4 kinase type 2 | 0.0167 | 0.6221 | 0.5 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0054 | 0.0901 | 0.5 |
Trichomonas vaginalis | low molecular weight protein-tyrosine-phosphatase, putative | 0.0209 | 0.8175 | 1 |
Onchocerca volvulus | 0.0169 | 0.6289 | 0.018 | |
Trichomonas vaginalis | low molecular weight protein-tyrosine-phosphatase, putative | 0.0209 | 0.8175 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0064 | 0.1385 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0038 | 0.0147 | 0.0147 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.0975 | 0.084 |
Brugia malayi | hypothetical protein | 0.0054 | 0.0901 | 0.0901 |
Schistosoma mansoni | phosphatidylinositol-4-phosphate 5-kinase type II | 0.0167 | 0.6221 | 1 |
Trichomonas vaginalis | low molecular weight protein-tyrosine-phosphatase, putative | 0.0209 | 0.8175 | 1 |
Mycobacterium tuberculosis | Phosphotyrosine protein phosphatase PtpA (protein-tyrosine-phosphatase) (PTPase) (LMW phosphatase) | 0.0145 | 0.5149 | 0.5 |
Loa Loa (eye worm) | phosphotyrosine protein phosphatase | 0.0209 | 0.8175 | 0.8148 |
Trichomonas vaginalis | low molecular weight protein tyrosine phosphatase, putative | 0.0209 | 0.8175 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0056 | 0.0975 | 0.0975 |
Brugia malayi | Low molecular weight phosphotyrosine protein phosphatase containing protein | 0.0209 | 0.8175 | 0.8175 |
Loa Loa (eye worm) | pip kinase 2 | 0.0167 | 0.6221 | 0.6164 |
Trypanosoma brucei | low molecular weight protein tyrosine phosphatase, putative | 0.0064 | 0.1385 | 1 |
Brugia malayi | hypothetical protein | 0.0169 | 0.6289 | 0.6289 |
Entamoeba histolytica | protein tyrosine phosphatase, putative | 0.0209 | 0.8175 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0169 | 0.6289 | 0.6234 |
Echinococcus multilocularis | phosphatidylinositol 5 phosphate 4 kinase type 2 | 0.0167 | 0.6221 | 0.5 |
Schistosoma mansoni | phosphatidylinositol-4-phosphate 5-kinase type II | 0.0167 | 0.6221 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0056 | 0.0975 | 0.084 |
Trichomonas vaginalis | low molecular weight protein tyrosine phosphatase, putative | 0.0209 | 0.8175 | 1 |
Brugia malayi | Pip kinase protein 2 | 0.0167 | 0.6221 | 0.6221 |
Onchocerca volvulus | 0.0209 | 0.8175 | 0.5172 | |
Entamoeba histolytica | protein tyrosine phosphatase, putative | 0.0209 | 0.8175 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0054 | 0.0901 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0167 | 0.6221 | 0.6164 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0064 | 0.1385 | 1 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0054 | 0.0901 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0054 | 0.0901 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0064 | 0.1385 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.